Plain-English translation of NCT07330830 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how genetic differences may explain why fatty liver disease affects people differently across different ethnic and geographic backgrounds. This study will enroll 600 adults from Caribbean and French overseas islands who have been diagnosed with metabolic-associated fatty liver disease (MASLD) to examine genetic variations that might influence disease risk and severity.
Fatty liver disease is affecting people worldwide at increasing rates, but some populations experience it more severely than others. Doctors don't fully understand whether these differences are due to genetics, lifestyle, diet, or a combination—and there's very little research on how this disease affects people in Caribbean and overseas French communities specifically.
You likely qualify if…
You likely don't qualify if…
As a participant, you will likely visit one of the study hospitals for an appointment where doctors will review your medical history, perform standard examinations, and collect blood or tissue samples for genetic analysis. The study is observational, meaning researchers are studying your genes and health information rather than giving you a new medication or treatment—you would continue your usual care while contributing to understanding how genetics influence fatty liver disease in your community.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
French Guiana
Guadeloupe
Reunion